Verismo Therapeutics

Verismo Therapeutics is a biopharmaceutical company dedicated to revolutionizing the treatment of solid tumors through its unique KIR-CAR platform technology. This cutting-edge platform leverages killer immunoglobulin-like receptors (KIRs) to create SynKIR™, a next-generation CAR T cell therapy that overcomes the limitations of traditional CAR T approaches. By mimicking the natural signaling of NK cells, SynKIR™ enhances T cell persistence and efficacy, even in the challenging microenvironment of solid tumors. Verismo’s groundbreaking technology has shown promising results in preclinical studies, leading to the initiation of clinical trials for various cancers.

Verismo is committed to translating its innovative science into life-saving treatments for patients. Founded by the inventors of Kymriah™, the first FDA-approved CAR T cell therapy, the company has a strong foundation of expertise and a shared vision to redefine the landscape of cancer treatment. Verismo continues to expand its research and development efforts, forging strategic collaborations and attracting top talent to advance the development of its SynKIR™ platform and bring hope to individuals battling solid tumors.

Verismo Therapeutics is a biotechnology company focused on pioneering a new generation of CAR T cell therapy for the treatment of solid tumors. Their paradigm-shifting KIR-CAR platform technology, SynKIR™, utilizes multi-chain immunoreceptors that are designed to overcome the limitations of traditional CAR T cell therapies, including T cell exhaustion. Verismo is dedicated to developing novel chimeric antigen receptors that mimic the natural design of killer immunoglobulin-like receptors (KIRs) to improve long-term T cell functionality and efficacy in challenging tumor microenvironments.

Verismo Therapeutics fosters a collaborative and innovative culture driven by cutting-edge research and a dedication to developing groundbreaking therapies for solid tumors. The company values its employees and prioritizes their engagement, with a focus on teamwork and professional development. There is a strong emphasis on scientific excellence and a shared commitment to making a difference in the lives of cancer patients. Verismo's culture is one of ambition, passion, and a commitment to pushing the boundaries of medicine.

Verismo Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They believe that a diverse team brings a wealth of perspectives and experiences, leading to more innovative solutions and stronger scientific breakthroughs in the fight against cancer. They strive to create an environment where everyone feels valued, respected, and empowered to contribute their unique talents, regardless of background, identity, or experience. This commitment is reflected in their efforts to attract and retain a diverse workforce, promote equitable opportunities for advancement, and create an inclusive culture where everyone feels welcome and supported.